Fidelity Seeds Ethereum ETF with $4.7M, Lowest Fee Yet by John Darbie 22.06.2024 "Fidelity seeds Ethereum ETF with $4.7M, marking a significant step before July launch. Other major players like BlackRock join competition."
Cooper Vetoes Controversial Bill on Protests and Campaign Finance by Mark Eisenberg 21.06.2024 Gov. Cooper vetoes bill altering NC's campaign finance, protest penalties, and mask rules; sparks debate on billionaire influence in elections.
Compliance Key to Hospice Investment and Growth Potential by Mark Eisenberg 21.06.2024 "Compliance is paramount for hospice investment growth. Private equity's interest spikes, focusing on sustainability, staff, and quality outcomes.
Bitcoin Price Prediction Amid $800B Giant’s BTC Trading by John Darbie 21.06.2024 Banking giant Standard Chartered launches BTC spot trading as it predicts Bitcoin could hit $150,000 by 2024 amid rising institutional ...
Cybersecurity Tops SME Concerns; AI Investment Varies Widely by Lilu Anderson 21.06.2024 Azets report reveals cybersecurity as top concern for Irish SMEs; recruitment set for largest investment, micro businesses lag in AI ...
Amazon Eyes Monthly Fee for Upgraded Alexa Service by Mark Eisenberg 21.06.2024 Amazon plans a major AI-powered Alexa revamp, introducing new tiers and features to compete with Google, Microsoft, and Apple.
Bitcoin Eyes $70K, Solana Pumps Ethereum, Cardano’s $0.3 Struggle by John Darbie 21.06.2024 Bitcoin eyes $70,000 amid momentum, Solana's uncertain rise vs. Ethereum, and Cardano's bounce around $0.3, facing mixed future prospects.
Solana Gains 25% DEX Market Share, Faces New Rival by John Darbie 21.06.2024 "Solana surges to capture 25% of DEX volume amid memecoin boom, driven by low fees and Phantom wallet's rise, challenging ...
Robinhood Acquires Bitstamp: A $200M Crypto Power Move by John Darbie 20.06.2024 Robinhood to acquire crypto exchange Bitstamp for $200M, expanding global reach. Deal expected to close in 2025, marking a major ...
Esperion Stock Downgraded Amid Merck’s Competitive Pressure by Mark Eisenberg 20.06.2024 Esperion's stock downgraded by BofA due to rising competition from Merck's PCSK9 inhibitors. Analysts weigh in on efficacy and market ...